About Us Contact Us Sitemap

Toxoplasmosis Testing Market, By Product Type (Test Kits, Reagents, Instruments and Analyzers, and Software Solutions), By Test Type, By Technology, By Sample Type, By End User, By Country, and By Region Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032

Market Research Image
Report ID AV4283
Published Date August 2025
Pages 398
Industry Healthcare
Format PPT/PDF
Base Year 2025
Historical Data 2019-2024
Delivery Timeline 24 Hour

REPORT HIGHLIGHT

Toxoplasmosis Testing Market size was valued at US$ 1,267 Million in 2024, expanding at a CAGR of 9.1% from 2025 to 2032.

The Toxoplasmosis Testing Market encompasses diagnostic procedures aimed at detecting Toxoplasma gondii infections, primarily through serological and molecular testing methods. Market growth is being fueled by the rising incidence of toxoplasmosis among immunocompromised individuals, pregnant women, and organ transplant recipients, particularly in regions with poor sanitation and low public health awareness.

The demand is further supported by increasing prenatal screening programs, especially across Europe and South America, along with the growing adoption of nucleic acid amplification tests (NAATs) in clinical laboratories. These advancements are enhancing the early detection and management of the infection. However, the market faces several challenges, including underreporting, limited public health surveillance, and inconsistent testing protocols, particularly in low-income regions, which hinder widespread adoption and diagnosis.

On the upside, the market presents significant growth opportunities, driven by rising R&D investments, continuous technological advancements in platforms such as PCR and ELISA, and increasing collaboration between diagnostic companies and public health organizations like the Centers for Disease Control and Prevention (CDC) and the World Health Organization (WHO). These efforts are expected to accelerate the development and accessibility of accurate and efficient toxoplasmosis diagnostics in the coming years.

Toxoplasmosis Testing Market- Market Dynamics

Rising Prenatal Screening and Advances in Diagnostics Drive Growth of the Toxoplasmosis Testing Market

The toxoplasmosis testing market is gaining significant traction, driven by heightened focus on prenatal care and infectious disease management. According to the CDC, over 40 million people in the U.S. are affected by toxoplasmosis, though the majority remain asymptomatic. Pregnant women and immunocompromised individuals are especially vulnerable, leading to the implementation of regular screening protocols in countries such as France, Austria, and Brazil.

In 2023, the European Centre for Disease Prevention and Control (ECDC) emphasized increasing awareness campaigns and advancements in diagnostic techniques across Eastern Europe to combat congenital infections. Concurrently, global initiatives like the WHO’s program targeting foodborne parasitic diseases have enhanced public health strategies, particularly in developing regions. Furthermore, growing collaborations between diagnostic laboratories and healthcare facilities, including the standardization of serological testing in public health clinics, are playing a crucial role in driving market growth.

Toxoplasmosis Testing Market- Segmentation Analysis:
The Global Toxoplasmosis Testing Market is segmented on the basis of Product Type, Test Type, Technology, Sample Type, End User, and Region.

The market for diagnostic solutions is segmented into four key product types: Test Kits, Reagents, Instruments and Analyzers, and Software Solutions. Among these, test kits hold the highest priority due to their widespread adoption in clinical laboratories and point-of-care settings, where rapid and reliable diagnostic results are critical. Their convenience and ease of use make them indispensable in scenarios such as infectious disease screening and routine health checks. Following test kits, reagents maintain strong demand driven by their recurring usage in various diagnostic assays. Instruments and analyzers are essential for processing and quantifying test results, but their higher cost limits their penetration compared to consumables. Meanwhile, software solutions are emerging as vital tools for data management and result interpretation, enhancing diagnostic accuracy and workflow efficiency. Government health agencies worldwide are actively supporting this market segment through funding and regulatory frameworks; for instance, the U.S. FDA’s Emergency Use Authorization (EUA) during the COVID-19 pandemic accelerated the approval and deployment of many test kits and reagents, facilitating faster diagnosis and better pandemic management.

Based on test types, the market is categorized into Serological Tests, Molecular Tests, Histological Tests, and Other diagnostic methods. Serological tests lead the market, favored for their cost-effectiveness and extensive clinical utility in detecting antibodies and antigens, especially in infectious diseases and immune status monitoring. The affordability and rapid turnaround times make serological testing highly accessible across diverse healthcare settings. Molecular tests, including PCR-based assays, are gaining traction, particularly in specialized and reference laboratories, due to their high sensitivity and specificity, which are critical for early and accurate diagnosis of complex diseases. Histological tests, involving tissue analysis, are less prevalent due to their invasive nature and longer processing times. Other test types contribute minimally to the overall market share. Governments globally are investing heavily in molecular diagnostics infrastructure; for example, the European Commission’s Horizon 2020 program has funded initiatives to advance molecular testing technologies, and countries like Germany and South Korea have expanded molecular test capacities in public health laboratories to enhance disease surveillance and control.

Toxoplasmosis Testing Market- Geographical Insights

In Europe, countries such as France and Austria have implemented routine prenatal toxoplasmosis screening programs, significantly enhancing early diagnosis and contributing to market growth. According to the European Centre for Disease Prevention and Control (ECDC), congenital toxoplasmosis remains a critical public health concern, particularly in Eastern Europe where infection rates are elevated. In North America, the Centers for Disease Control and Prevention (CDC) actively promotes awareness and preventive testing among pregnant women and immunocompromised populations, supported by strong collaborations with public health departments and diagnostic laboratories.

Meanwhile, Brazil’s Ministry of Health has intensified toxoplasmosis surveillance as part of its congenital infection control program, improving diagnostic accessibility in public hospitals. In 2024, partnerships between university hospitals and diagnostic reagent manufacturers in Brazil and Argentina advanced localized development of serological testing, further strengthening regional diagnostic capabilities. These region-specific initiatives and institutional collaborations are playing an essential role in improving toxoplasmosis detection and control within global healthcare systems.

Toxoplasmosis Testing Market- Competitive Landscape:

The toxoplasmosis testing market is moderately competitive, featuring several diagnostic companies and research institutions dedicated to improving test sensitivity and affordability. Leading players such as Bio-Rad Laboratories, Abbott, and DiaSorin continue to drive innovation in serological assay development through partnerships with academic and public health organizations.

In 2024, DiaSorin collaborated with the University of Milan to enhance IgG avidity testing for early toxoplasmosis detection during pregnancy. Similarly, the Pasteur Institute partnered with diagnostic startups in France to accelerate the development of rapid test kits suitable for low-resource settings. Abbott expanded its molecular diagnostics portfolio by integrating pathogen-specific PCR platforms, encompassing parasitic infections including Toxoplasma gondii. On a regional level, Brazil’s Fiocruz has joined forces with local biotech companies to manufacture ELISA test kits, reducing dependence on imported diagnostics. These strategic alliances and public-private partnerships are fortifying global testing infrastructure and facilitating the wider adoption of advanced toxoplasmosis diagnostics.

Recent Developments:

  • May 2024: The University of Chicago and LDBIO Diagnostics launched the Toxoplasma ICT IgGIgM, a rapid point-of-care test that delivers accurate results within 30 minutes from a finger-prick sample. This test boasts over 97.5% sensitivity and 100% specificity, significantly reducing false positives and enhancing prenatal screening precision.
  • May 2025: Researchers at the National Institute of Animal Biotechnology (NIAB) in Hyderabad utilized CRISPR-based genetic techniques to identify a Toxoplasma gondii protein potentially critical in preventing zoonotic transmission and congenital toxoplasmosis. This breakthrough aligns with WHO and FAO priorities addressing foodborne parasitic diseases.

SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:

GLOBAL TOXOPLASMOSIS TESTING MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Abbott Laboratories
  • ARUP Laboratories
  • Becton, Dickinson and Company
  • bioMérieux
  • Bio-Rad Laboratories
  • Creative Diagnostics
  • Danaher Corporation
  • DiaSorin
  • F. Hoffmann-La Roche
  • Luminex Corporation
  • NovaTec Immundiagnostica
  • Omega Diagnostics
  • Ortho Clinical Diagnostics
  • QIAGEN
  • Randox Laboratories
  • Siemens Healthineers
  • Thermo Fisher Scientific
  • Trinity Biotech
  • Vircell
  • ZEUS Scientific
  • Others

GLOBAL TOXOPLASMOSIS TESTING MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2019 - 2032

  • Test Kits
  • Reagents
  • Instruments and Analyzers
  • Software Solutions

GLOBAL TOXOPLASMOSIS TESTING MARKET, BY TEST TYPE- MARKET ANALYSIS, 2019 - 2032

  • Serological Tests
  • Molecular Tests
  • Histological Tests
  • Other

GLOBAL TOXOPLASMOSIS TESTING MARKET, BY TECHNOLOGY- MARKET ANALYSIS, 2019 - 2032

  • Enzyme-Linked Immunosorbent Assay (ELISA)
  • Polymerase Chain Reaction (PCR)
  • Others

GLOBAL TOXOPLASMOSIS TESTING MARKET, BY SAMPLE TYPE- MARKET ANALYSIS, 2019 - 2032

  • Blood
  • Amniotic Fluid
  • Cerebrospinal Fluid
  • Other

GLOBAL TOXOPLASMOSIS TESTING MARKET, BY END USER- MARKET ANALYSIS, 2019 - 2032

  • Hospitals
  • Diagnostic Laboratories
  • Research Institutions
  • Homecare Settings

GLOBAL TOXOPLASMOSIS TESTING MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

North America

  • U.S.
  • Canada

Europe

  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Sweden
  • Russia
  • Poland
  • Rest of Europe

Asia Pacific

  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Philippines
  • Rest of APAC

Latin America

  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM

The Middle East and Africa

  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

TABLE OF CONTENT

1. Toxoplasmosis Testing Market Overview
1.1. Study Scope
1.2. Market Estimation Years
2. Executive Summary
2.1. Market Snippet
2.1.1. Toxoplasmosis Testing Market Snippet by Product Type
2.1.2. Toxoplasmosis Testing Market Snippet by Test Type
2.1.3. Toxoplasmosis Testing Market Snippet by Technology
2.1.4. Toxoplasmosis Testing Market Snippet by Sample Type
2.1.5. Toxoplasmosis Testing Market Snippet by End User
2.1.6. Toxoplasmosis Testing Market Snippet by Country
2.1.7. Toxoplasmosis Testing Market Snippet by Region
2.2. Competitive Insights
3. Toxoplasmosis Testing Key Market Trends
3.1. Toxoplasmosis Testing Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. Toxoplasmosis Testing Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. Toxoplasmosis Testing Market Opportunities
3.4. Toxoplasmosis Testing Market Future Trends
4. Toxoplasmosis Testing Industry Study
4.1. PEST Analysis
4.2. Porter’s Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis
5. Toxoplasmosis Testing Market: Impact of Escalating Geopolitical Tensions
5.1. Impact of COVID-19 Pandemic
5.2. Impact of Russia-Ukraine War
5.3. Impact of Middle East Conflicts
6. Toxoplasmosis Testing Market Landscape
6.1. Toxoplasmosis Testing Market Share Analysis, 2024
6.2. Breakdown Data, by Key Manufacturer
6.2.1. Established Players’ Analysis
6.2.2. Emerging Players’ Analysis
7. Toxoplasmosis Testing Market – By Product Type
7.1. Overview
7.1.1. Segment Share Analysis, By Product Type, 2024 & 2032 (%)
7.1.2. Test Kits
7.1.3. Reagents
7.1.4. Instruments and Analyzers
7.1.5. Software Solutions
8. Toxoplasmosis Testing Market – By Test Type
8.1. Overview
8.1.1. Segment Share Analysis, By Test Type, 2024 & 2032 (%)
8.1.2. Serological Tests
8.1.3. Molecular Tests
8.1.4. Histological Tests
8.1.5. Other
9. Toxoplasmosis Testing Market – By Technology
9.1. Overview
9.1.1. Segment Share Analysis, By Technology, 2024 & 2032 (%)
9.1.2. Enzyme-Linked Immunosorbent Assay (ELISA)
9.1.3. Polymerase Chain Reaction (PCR)
9.1.4. Others
10. Toxoplasmosis Testing Market – By Sample Type
10.1. Overview
10.1.1. Segment Share Analysis, By Sample Type, 2024 & 2032 (%)
10.1.2. Blood
10.1.3. Amniotic Fluid
10.1.4. Cerebrospinal Fluid
10.1.5. Other Body Fluids
11. Toxoplasmosis Testing Market – By End User
11.1. Overview
11.1.1. Segment Share Analysis, By End User, 2024 & 2032 (%)
11.1.2. Hospitals
11.1.3. Diagnostic Laboratories
11.1.4. Research Institutions
11.1.5. Homecare Settings
12. Toxoplasmosis Testing Market– By Geography
12.1. Introduction
12.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
12.2. North America
12.2.1. Overview
12.2.2. Toxoplasmosis Testing Key Manufacturers in North America
12.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
12.2.4. North America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.2.5. North America Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
12.2.6. North America Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.2.7. North America Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
12.2.8. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.2.9. U.S.
12.2.9.1. Overview
12.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.2.9.3. U.S. Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.2.9.4. U.S. Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
12.2.9.5. U.S. Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.2.9.6. U.S. Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
12.2.9.7. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.2.10. Canada
12.2.10.1. Overview
12.2.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.2.10.3. Canada Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.2.10.4. Canada Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
12.2.10.5. Canada Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.2.10.6. Canada Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
12.2.10.7. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.3. Europe
12.3.1. Overview
12.3.2. Toxoplasmosis Testing Key Manufacturers in Europe
12.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
12.3.4. Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.3.5. Europe Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
12.3.6. Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.3.7. Europe Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
12.3.8. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.3.9. Germany
12.3.9.1. Overview
12.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.9.3. Germany Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.3.9.4. Germany Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
12.3.9.5. Germany Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.3.9.6. Germany Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
12.3.9.7. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.3.10. UK
12.3.10.1. Overview
12.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.10.3. UK Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.3.10.4. UK Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
12.3.10.5. UK Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.3.10.6. UK Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
12.3.10.7. UK Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.3.11. France
12.3.11.1. Overview
12.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.11.3. France Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.3.11.4. France Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
12.3.11.5. France Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.3.11.6. France Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
12.3.11.7. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.3.12. Italy
12.3.12.1. Overview
12.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.12.3. Italy Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.3.12.4. Italy Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
12.3.12.5. Italy Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.3.12.6. Italy Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
12.3.12.7. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.3.13. Spain
12.3.13.1. Overview
12.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.13.3. Spain Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.3.13.4. Spain Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
12.3.13.5. Spain Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.3.13.6. Spain Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
12.3.13.7. Spain Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.3.14. The Netherlands
12.3.14.1. Overview
12.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.14.3. The Netherlands Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.3.14.4. The Netherlands Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
12.3.14.5. The Netherlands Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.3.14.6. The Netherlands Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
12.3.14.7. The Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.3.15. Sweden
12.3.15.1. Overview
12.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.15.3. Sweden Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.3.15.4. Sweden Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
12.3.15.5. Sweden Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.3.15.6. Sweden Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
12.3.15.7. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.3.16. Russia
12.3.16.1. Overview
12.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.16.3. Russia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.3.16.4. Russia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
12.3.16.5. Russia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.3.16.6. Russia Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
12.3.16.7. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.3.17. Poland
12.3.17.1. Overview
12.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.17.3. Poland Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.3.17.4. Poland Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
12.3.17.5. Poland Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.3.17.6. Poland Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
12.3.17.7. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.3.18. Rest of Europe
12.3.18.1. Overview
12.3.18.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.18.3. Rest of the Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.3.18.4. Rest of the Europe Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
12.3.18.5. Rest of the Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.3.18.6. Rest of the Europe Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
12.3.18.7. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.4. Asia Pacific (APAC)
12.4.1. Overview
12.4.2. Toxoplasmosis Testing Key Manufacturers in Asia Pacific
12.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
12.4.4. APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.4.5. APAC Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
12.4.6. APAC Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.4.7. APAC Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
12.4.8. APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.4.9. China
12.4.9.1. Overview
12.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.4.9.3. China Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.4.9.4. China Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
12.4.9.5. China Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.4.9.6. China Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
12.4.9.7. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.4.10. India
12.4.10.1. Overview
12.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.4.10.3. India Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.4.10.4. India Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
12.4.10.5. India Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.4.10.6. India Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
12.4.10.7. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.4.11. Japan
12.4.11.1. Overview
12.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.4.11.3. Japan Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.4.11.4. Japan Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
12.4.11.5. Japan Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.4.11.6. Japan Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
12.4.11.7. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.4.12. South Korea
12.4.12.1. Overview
12.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.4.12.3. South Korea Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.4.12.4. South Korea Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
12.4.12.5. South Korea Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.4.12.6. South Korea Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
12.4.12.7. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.4.13. Australia
12.4.13.1. Overview
12.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.4.13.3. Australia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.4.13.4. Australia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
12.4.13.5. Australia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.4.13.6. Australia Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
12.4.13.7. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.4.14. Indonesia
12.4.14.1. Overview
12.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.4.14.3. Indonesia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.4.14.4. Indonesia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
12.4.14.5. Indonesia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.4.14.6. Indonesia Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
12.4.14.7. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.4.15. Thailand
12.4.15.1. Overview
12.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.4.15.3. Thailand Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.4.15.4. Thailand Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
12.4.15.5. Thailand Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.4.15.6. Thailand Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
12.4.15.7. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.4.16. Philippines
12.4.16.1. Overview
12.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.4.16.3. Philippines Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.4.16.4. Philippines Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
12.4.16.5. Philippines Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.4.16.6. Philippines Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
12.4.16.7. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.4.17. Rest of APAC
12.4.17.1. Overview
12.4.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.4.17.3. Rest of APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.4.17.4. Rest of APAC Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
12.4.17.5. Rest of APAC Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.4.17.6. Rest of APAC Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
12.4.17.7. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.5. Latin America (LATAM)
12.5.1. Overview
12.5.2. Toxoplasmosis Testing Key Manufacturers in Latin America
12.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
12.5.4. LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.5.5. LATAM Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
12.5.6. LATAM Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.5.7. LATAM Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
12.5.8. LATAM Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.5.9. Brazil
12.5.9.1. Overview
12.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.5.9.3. Brazil Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.5.9.4. Brazil Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
12.5.9.5. Brazil Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.5.9.6. Brazil Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
12.5.9.7. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.5.10. Mexico
12.5.10.1. Overview
12.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.5.10.3. Mexico Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.5.10.4. Mexico Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
12.5.10.5. Mexico Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.5.10.6. Mexico Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
12.5.10.7. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.5.11. Argentina
12.5.11.1. Overview
12.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.5.11.3. Argentina Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.5.11.4. Argentina Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
12.5.11.5. Argentina Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.5.11.6. Argentina Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
12.5.11.7. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.5.12. Colombia
12.5.12.1. Overview
12.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.5.12.3. Colombia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.5.12.4. Colombia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
12.5.12.5. Colombia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.5.12.6. Colombia Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
12.5.12.7. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.5.13. Rest of LATAM
12.5.13.1. Overview
12.5.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.5.13.3. Rest of LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.5.13.4. Rest of LATAM Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
12.5.13.5. Rest of LATAM Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.5.13.6. Rest of LATAM Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
12.5.13.7. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.6. Middle East and Africa
12.6.1. Overview
12.6.2. Toxoplasmosis Testing Key Manufacturers in Middle East and Africa
12.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
12.6.4. Middle East and Africa Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.6.5. Middle East and Africa Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
12.6.6. Middle East and Africa Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.6.7. Middle East and Africa Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
12.6.8. Middle East and Africa Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.6.9. Saudi Arabia
12.6.9.1. Overview
12.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.6.9.3. Saudi Arabia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.6.9.4. Saudi Arabia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
12.6.9.5. Saudi Arabia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.6.9.6. Saudi Arabia Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
12.6.9.7. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.6.10. United Arab Emirates
12.6.10.1. Overview
12.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.6.10.3. United Arab Emirates Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.6.10.4. United Arab Emirates Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
12.6.10.5. United Arab Emirates Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.6.10.6. United Arab Emirates Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
12.6.10.7. United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.6.11. Israel
12.6.11.1. Overview
12.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.6.11.3. Israel Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.6.11.4. Israel Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
12.6.11.5. Israel Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.6.11.6. Israel Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
12.6.11.7. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.6.12. Turkey
12.6.12.1. Overview
12.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.6.12.3. Turkey Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.6.12.4. Turkey Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
12.6.12.5. Turkey Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.6.12.6. Turkey Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
12.6.12.7. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.6.13. Algeria
12.6.13.1. Overview
12.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.6.13.3. Algeria Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.6.13.4. Algeria Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
12.6.13.5. Algeria Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.6.13.6. Algeria Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
12.6.13.7. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.6.14. Egypt
12.6.14.1. Overview
12.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.6.14.3. Egypt Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.6.14.4. Egypt Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
12.6.14.5. Egypt Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.6.14.6. Egypt Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
12.6.14.7. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.6.15. Rest of MEA
12.6.15.1. Overview
12.6.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.6.15.3. Rest of MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.6.15.4. Rest of MEA Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
12.6.15.5. Rest of MEA Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.6.15.6. Rest of MEA Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
12.6.15.7. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
13. Key Vendor Analysis- Toxoplasmosis Testing Industry
13.1. Competitive Dashboard
13.1.1. Competitive Benchmarking
13.1.2. Competitive Positioning
13.2. Company Profiles
13.2.1. Abbott Laboratories
13.2.2. ARUP Laboratories
13.2.3. Becton, Dickinson and Company
13.2.4. bioMérieux
13.2.5. Bio-Rad Laboratories
13.2.6. Creative Diagnostics
13.2.7. Danaher Corporation
13.2.8. DiaSorin
13.2.9. F. Hoffmann-La Roche
13.2.10. Luminex Corporation
13.2.11. NovaTec Immundiagnostica
13.2.12. Omega Diagnostics
13.2.13. Ortho Clinical Diagnostics
13.2.14. QIAGEN
13.2.15. Randox Laboratories
13.2.16. Siemens Healthineers
13.2.17. Thermo Fisher Scientific
13.2.18. Trinity Biotech
13.2.19. Vircell
13.2.20. ZEUS Scientific
13.2.21. Others
14. 360 Degree Analyst View
15. Appendix
15.1. Research Methodology
15.2. References
15.3. Abbreviations
15.4. Disclaimer
15.5. Contact Us

Request For Sample
Choose License Type
assit assit
Related Reports

Credibility and Certifications

Trusted Insights, Certified Excellence! Coherent Market Insights is a certified data advisory and business consulting firm recognized by global institutes.

ISO Certification ISO 9001:2015
ESOMAR Individual ESOMAR Corporate
GDPR Compliance GDPR Compliance
D-U-N-S Registered D-U-N-S Registered
BBB Accreditation BBB Accreditation
MRS MRS
CONTACT INFORMATION

Email:

[email protected]

U.S. Office

11923 NE Sumner St STE 750924
Portland, Oregon, 97220, USA

Asia Pacific Office

4, Rohan Business Centre, Paud Road,
Kothrud, Pune Maharashtra, 411038, India

QUICK LINKS
RESOURCES
Secure Payment By
PayPal
Visa
MasterCard
American Express
Support Hours

We’re here to assist you around the clock, six days a week.

Monday – Friday: 10:00 AM to 6:00 PM

Saturday: 10:00 AM to 3:00 PM

Sunday: Closed

© Copyright 2026 Analystview Market Insights | All Rights Reserved